Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain.
Examining multiple sclerosis through the eyes of a child.
The role of the sema4D/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.
Morning glory syndrome associated with multiple sclerosis.
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.
Management of pain in advanced disease.
Treatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year Follow-Up and Literature Review.
Opexa's Tovaxin® for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
Effects of propentofylline on CNS remyelination in the rat brainstem.
Five years follow-up study and failures analysis of Botulinum toxin repeated injections to treat neurogenic detrusor overactivity.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.
Does HLA Class II Haplotype play a role in Adult Acute Disseminated Encephalomyelitis? Preliminary Findings from a Southern Italy hospital-based study.
Cognitive and psychosocial issues in pediatric multiple sclerosis: where we are and where we need to go.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.
Pages
« first
‹ previous
…
323
324
325
326
327
328
329
330
331
…
next ›
last »